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Increased risk of miscarriage has been reported for women with specific chronic health con-
ditions. A broader investigation of chronic diseases and miscarriage risk may uncover pat-
terns across categories of illness. The objective of this study was to study the risk of
miscarriage according to various preexisting chronic diseases.
Methods and findings
We conducted a registry-based study. Registered pregnancies (n = 593,009) in Norway
between 2010 and 2016 were identified through 3 national health registries (birth register,
general practitioner data, and patient registries). Six broad categories of illness were identi-
fied, comprising 25 chronic diseases defined by diagnostic codes used in general practi-
tioner and patient registries. We required that the diseases were diagnosed before the
pregnancy of interest. Miscarriage risk according to underlying chronic diseases was esti-
mated as odds ratios (ORs) using generalized estimating equations adjusting for woman’s
age. The mean age of women at the start of pregnancy was 29.7 years (SD 5.6 years). We
observed an increased risk of miscarriage among women with cardiometabolic diseases
(OR 1.25, 95% CI 1.20 to 1.31; p-value <0.001). Within this category, risks were elevated for
all conditions: atherosclerosis (2.22; 1.42 to 3.49; p-value <0.001), hypertensive disorders
(1.19; 1.13 to 1.26; p-value <0.001), and type 2 diabetes (1.38; 1.26 to 1.51; p-value
<0.001). Among other categories of disease, risks were elevated for hypoparathyroidism
(2.58; 1.35 to 4.92; p-value 0.004), Cushing syndrome (1.97; 1.06 to 3.65; p-value 0.03),
Crohn’s disease (OR 1.31; 95% CI: 1.18 to 1.45; p-value 0.001), and endometriosis (1.22;
1.15 to 1.29; p-value <0.001). Findings were largely unchanged after mutual adjustment.
Limitations of this study include our inability to adjust for measures of socioeconomic posi-
tion or lifestyle characteristics, in addition to the rareness of some of the conditions providing
limited power.
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Conclusions
In this registry study, we found that, although risk of miscarriage was largely unaffected by
maternal chronic diseases, risk of miscarriage was associated with conditions related to car-
diometabolic health. This finding is consistent with emerging evidence linking cardiovascular
risk factors to pregnancy complications.
Author summary
Why was this study done?
• Scattered findings indicate that women with different chronic disease have an increased
risk of miscarriage.
• To our knowledge, none of the existing studies have evaluated a broader range of
chronic diseases to further evaluate the role of common as opposed to independent bio-
logical mechanisms.
What did the researchers do and find?
• With linked data from Norwegian national registries (including 593,009 pregnancies),
we examined the risk of miscarriage according to 25 different chronic diseases diag-
nosed prior to pregnancy.
• Although risk of miscarriage was largely unaffected by maternal chronic diseases, risk of
miscarriage was associated with conditions related to cardiometabolic health.
• Other conditions associated with risk of miscarriage included hypoparathyroidism,
Cushing syndrome, Crohn’s disease, and endometriosis.
What do these findings mean?
• This finding is consistent with emerging evidence linking cardiovascular risk factors to
pregnancy complications.
• Further investigation is necessary to better understand the underlying mechanisms
resulting in an increased risk of miscarriage across a range of chronic diseases.
Introduction
Miscarriage occurs in 12% to 15% of recognized pregnancies [1–4]. Although the underlying
cause of most miscarriages is unknown, they presumably result from a complex interplay
between parental age, genetic, hormonal, metabolic, immunological, and environmental fac-
tors [5,6]. Genetic factors, including parental chromosomal rearrangements and abnormal
embryonic genotypes or karyotypes, are found in more than half of recurrent miscarriages [6].
Various studies of specific illnesses have suggested an association with risk of miscarriage.
These include systemic lupus erythematosus [7], type 1 diabetes [8,9], celiac disease [10,11],
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asthma/allergies [12], thyroid disorders [13–16], Addison disease [17,18], type 2 diabetes
[9,19,20], parathyroid disorders [21,22], Cushing syndrome [23], migraine [24], and epilepsy
[25,26]. These scattered findings suggest that immunological, metabolic, or endocrinological
mechanisms might be linked to miscarriage risk, any of which is biologically plausible since all
play a role in development and function of the placenta [27–30]. However, most of these stud-
ies were based on relatively small samples, and most are retrospective and therefore susceptible
to recall bias.
The Norwegian health registries contain comprehensive registration of all recognized preg-
nancies resulting in contact with healthcare services. Our objective was to study the risk of
miscarriage in relation to women’s chronic illness present prior to pregnancy. We examined
the risk of miscarriage across a broad range of illnesses, including autoimmune, cardiometa-
bolic, endocrinological, neurological, allergic, and reproductive.
Methods
This study is reported as per the Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) and REporting of studies Conducted using Observational Routinely-
collected Data (RECORD) guidelines (S1 RECORD Checklist). The study was conducted
according to a prespecified analysis plan (S1 Analysis Plan). The only deviation from this plan
was that we not only evaluated the risk of miscarriage according to the individual chronic dis-
eases but also according to subgroups which might share underlying disease pathways.
Study population and data sources
We conducted a registry-based study using Norwegian national registries. The study popula-
tion consisted of all registered pregnancies in Norway with an estimated date of conception
between January 1, 2010 and December 31, 2016. Information on pregnancies came from 3
national health registries: the Medical Birth Registry of Norway, the Norwegian Patient Regis-
try, and the general practitioner database. Hospital discharges in the patient registry are coded
according to International Classification of Diseases (ICD) version 10, while the general practi-
tioner database is coded according to the International Classification of Primary Care (ICPC-
2) [31]. The birth registry includes information on all pregnancies ending at 12 gestational
weeks or later (live births, stillbirths, late miscarriages, and late induced abortions). Miscar-
riages before 12 weeks were captured by registrations in the patient registry (with information
on all contact with specialist healthcare services) and by the general practitioner database (with
information on all contact with primary healthcare services). We used information from the
patient registry to account for induced abortions. Ectopic pregnancies were excluded from the
study. We linked information from the 3 health registries by using the unique personal identi-
fication numbers given to all Norwegian citizens. A description of the data sources and linkage
procedures is provided in the Supplement Methods (S1 Text). The analysis was based on de-
identified data. The study was approved and participant consent was waived by the Regional
Committee for Medical and Health Research Ethics South-East, reference number 2014/404.
Pregnancy outcomes and identification of unique pregnancies
We identified live births and fetal deaths after 12 gestational weeks through the birth registry.
We defined stillbirth as a fetal death at 20 gestational weeks or later, or death of a fetus with a
birthweight of 500 grams or more. Miscarriage were defined as fetal deaths before 20 gesta-
tional weeks where the fetus also had a birthweight less than 500 grams. In addition, we used
the patient registry to capture miscarriages before 12 completed gestational weeks using the
following ICD-10 codes: hydatidiform mole (O01); blighted ovum and nonhydatidiform mole
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(O02.0); missed abortion (O02.1); other specified abnormal products of conception (O02.8);
abnormal product of conception, unspecified (O02.9); spontaneous abortion (O03); and
threatened abortion (O20.0). These are the diagnostic codes we previously used to identify
miscarriages in the patient registry [32]. The following ICD-10 codes were used to define
induced abortions in the patient registry: medical abortion (O04), other abortion (O05), and
unspecified abortion (O06).
The present study expands our earlier definition of miscarriage by including events
reported in the general practitioner database [32]. Registrations of bleeding in pregnancy
(ICPC-2 code W03) or spontaneous abortion (ICPC-2 code W82) in the general practitioner
database were included as miscarriages if there was no subsequent registration of delivery or
birth.
Pregnancies in the patient and general practitioner databases are not registered with unique
pregnancy IDs, which means that follow-up visits for the same miscarriage produce multiple
registrations. We took the following steps to define unique pregnancies. First, we required a
minimum of 6 weeks (42 days) between 2 successive records of miscarriage in the patient reg-
istry, and a minimum of 3 months (90 days) between 2 successive records of miscarriage in the
general practitioner database, to consider them distinct pregnancies. These cutoffs were cho-
sen by inspecting the distribution of the time between registrations in the 2 registers. We
used a longer time interval between the registrations in the general practitioner database,
because women may have more and longer duration of follow-up visits with their general prac-
titioners after a miscarriage. The routine postpartum checkup is done in general practice 6
weeks after delivery, and we required at least additional 6 weeks for the next registration to be
defined as a new pregnancy. Second, we required that a record of a miscarriage or induced
abortion in the patient or general practice databases be at least 6 weeks (patient registry) or 3
months (general practitioner database) after a registered delivery in the birth registry. Third,
we excluded events registered as miscarriages or induced abortions that occurred within the
gestational period of a registered pregnancy in the birth registry. For the 2 codes of threatened
abortion (patient registry) and bleeding during pregnancy (general practitioner database),
these were counted as miscarriages only if they did not have another code indicating the out-
come of the pregnancy within 90 days.
Maternal chronic diseases
Diagnoses of chronic diseases were obtained from the patient and general practitioner data-
bases. We included autoimmune diseases (autoimmune thyroiditis, systemic lupus erythema-
tosus, type 1 diabetes, celiac disease, multiple sclerosis, rheumatoid arthritis/ankylosing
spondylitis, ulcerative colitis, psoriasis, Addison disease, Crohn’s disease, haemolytic anemia),
endocrinological diseases (Cushing syndrome, hypothyroidism, hyperthyroidism, hyperaldos-
teronism, hyperparathyroidism), cardiometabolic diseases (atherosclerosis, hypertensive dis-
orders, type 2 diabetes), allergic diseases (asthma, allergic rhinitis, atopic dermatitis),
neurological diseases (epilepsy, migraine), and reproductive diseases (polycystic ovary syn-
drome (PCOS) and endometriosis). We decided a priori what chronic diseases to include as
exposures. The only notable changes based on what was decided a priori was the inclusion of
an analysis of any cardiometabolic, any autoimmune, any reproductive, any endocrinological,
any allergic, and any neurological diseases. In addition, autoimmune thyroiditis was included
as part of review process. The various ICD-10 codes (specialist healthcare services) and ICPC-
2 codes (primary healthcare services) used to capture the chronic disorders are listed in S1
Table. To reduce potential misclassification, we required 2 or more registrations of these
PLOS MEDICINE Chronic diseases and miscarriage
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diagnostic codes, with at least 1 registration prior to the pregnancy of interest. We estimated
the duration of pregnancies in the birth registry by subtracting the estimated gestational age in
days from the date of the birth. Since we did not have information on the gestational age of
miscarriages or induced abortions identified in the patient and general practitioner databases,
we required that a diagnosis of chronic diseases for these pregnancies be at least 12 weeks
prior. Pregnancies with longer gestation than 12 weeks should be recorded in the birth
registry.
Statistical analysis
We used generalized estimating equations with an exchangeable correlation structure to calcu-
late the odds ratios (ORs) of miscarriage according to chronic conditions. We adjusted for the
woman’s age at the start of pregnancy as a linear and squared term. We conducted additional
multivariable analyses adjusting for the number of previous pregnancies. We also explored
multivariable analyses with mutual adjustment for all underlying chronic diseases in the same
model.
The risk of miscarriage is typically defined as the number of miscarriages divided by the
sum of miscarriages and births. This definition does not take into account the competing risk
of induced abortions. Pregnant women who intend to terminate their pregnancy are at risk of
miscarriage up to the time of termination, but (by definition) there is no risk of birth. Miscar-
riages among these pregnancies contribute to the numerator of miscarriage risk with no corre-
sponding contribution to the denominator, thus inflating the risk estimate for miscarriage.
This bias can be adjusted by adding a portion of induced abortions to the denominator of mis-
carriage risk. We included 20% of induced abortions in the comparison group to account for
the competing risk due to induced abortions. Details on the calculation of this adjustment
value are provided in the Supplement Methods (S1 Text).
We explored stratified analyses by age (<35 years and 35 years and older) and by registra-
tion of the miscarriage in the specialist versus primary healthcare services. We also conducted
a sensitivity analysis excluding molar pregnancies from the definition of miscarriage.
All analyses were conducted using STATA version 15 (Statacorp, Texas).
Patient and public involvement
No patients were involved in setting the research question or the outcome measures, nor were
they involved in developing plans for recruitment, design, or implementation of the study. No
patients were asked to advise on interpretation or writing up of results. There are no plans to
disseminate the results of the research to study participants or the relevant patient community.
Results
We identified 593,009 pregnancies to 278,159 women with an estimated date of conception
between January 1, 2010 and December 31, 2016 (Fig 1). Of these pregnancies, 409,952
(69.1%) ended in a live birth, 1,740 (0.3%) in stillbirth, 95,641 (16.1%) in induced abortion,
while 85,676 (14.5%) in miscarriage. Miscarriage risk as a proportion of miscarriages plus live
and stillbirths was 17.3%, reduced to 16.6% after adjusting for the competing risk of induced
abortions. The mean age of women at the start of pregnancy was 29.7 years (SD 5.6 years).
Fewer than 18% of women had a recorded chronic illness before pregnancy (Table 1), with the
most common condition being allergic rhinitis (4%).
After adjusting for women’s age, the category of illness with the strongest relation to mis-
carriage risk was cardiometabolic diseases (OR 1.25; 95% CI: 1.20, 1.31; p-value <0.001)
(Fig 2). All 3 conditions in this category had substantial associations with miscarriage risk:
PLOS MEDICINE Chronic diseases and miscarriage
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Fig 1. Illustration of identification of unique pregnancies across the birth, patient, and general practitioner
databases.
https://doi.org/10.1371/journal.pmed.1003603.g001
Table 1. Prevalence of chronic diseases prior to pregnancy among 593,009 pregnancies in Norway between 2010 and 2016.
Group of diseases Diseases No. pregnancies to women with underlying
chronic diseases (% out of all pregnancies)
No. pregnancies to women with chronic diseases ending
in a miscarriage (% out of exposed pregnancies)
Autoimmune
diseases
Type 1 diabetes 1,808 (0.30) 289 (18.6)
Celiac disease 791 (0.13) 130 (18.8)
Systemic lupus erythematosus 246 (0.04) 43 (20.2)
Multiple sclerosis 720 (0.12) 162 (19.4)
Rheumatoid arthritis/
Ankylosing spondylitis
2,559 (0.43) 418 (18.7)
Ulcerative colitis 2,817 (0.48) 456 (18.3)
Psoriasis 3,160 (0.53) 601 (17.4)
Crohn’s disease 1,603 (0.27) 289 (21.0)
Addison disease 56 (0.01) 11 (22.9)
Haemolytic anemia 194 (0.03) 34 (21.1)
Autoimmune thyroiditis 455 (0.08) 80 (20.9)
Cardiometabolic
diseases
Type 2 diabetes 1,951 (0.33) 428 (25.1)
Hypertensive disorders 5,334 (0.90) 1,085 (23.2)
Atherosclerosis 66 (0.01) 21 (42.9)
Endocrinological
diseases
Hypothyroidism 8,372 (1.41) 1,394 (18.6)
Hyperthyroidism 2,374 (0.40) 378 (18.1)
Hypoparathyroidism 29 (0.005) 9 (34.6)
Hyperparathyroidism 128 (0.02) 22 (21.0)
Cushing syndrome 31 (0.01) 10 (34.4)
Neurological diseases Epilepsy 2,563 (0.43) 375 (17.8)
Migraine 18,594 (3.14) 2,851 (17.7)
Allergic diseases Asthma 16,294 (2.75) 2,405 (17.4)
Allergic rhinitis 23,652 (3.99) 3,393 (16.2)
Atopic dermatitis 7,674 (1.29) 1,020 (15.6)
Reproductive
diseases
Polycystic ovary syndrome 83 (0.01) 20 (24.7)
Endometriosis 4,827 (0.81) 1,011 (22.4)
https://doi.org/10.1371/journal.pmed.1003603.t001
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atherosclerosis (OR 2.22; 95% CI: 1.42 to 3.49; p-value <0.001), type 2 diabetes (OR 1.38; 95%
CI: 1.26 to 1.51; p-value <0.001), and hypertensive disorders (OR 1.19; 95% CI: 1.13 to 1.26; p-
value <0.001). The category of reproductive diseases was the only other category with substan-
tial risk (OR 1.22; 95% CI: 1.15, 1.29; p-value<0.001), although there were only 2 conditions
in this category (endometriosis (OR 1.22; 95% CI: 1.15 to 1.29; p-value <0.001) and PCOS
(OR 1.34; 95% CI: 0.87 to 2.08; p-value 0.2).
Among the other categories, a few conditions showed strong associations, including hypo-
parathyroidism (OR 2.58; 95% CI: 1.35 to 4.92; p-value 0.004), Cushing syndrome (OR 1.97;
Fig 2. Adjusted odds ratios (ORs)� of miscarriage according to the presence of chronic conditions prior to the start of pregnancy (n = 593,009).
�The ORs are adjusted for the woman’s age at the start of pregnancy as a linear and a squared term.
https://doi.org/10.1371/journal.pmed.1003603.g002
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95% CI: 1.06 to 3.65; p-value 0.03), Crohn’s disease (OR 1.31; 95% CI: 1.18 to 1.45; p-value
<0.001), and type 1 diabetes (OR 1.11; 95% CI: 1.01, 1.23; p-value 0.04). Adjustment for wom-
an’s age was important for unbiased estimates, as shown by the attenuation of the unadjusted
results (S1 Fig). The sensitivity analysis excluding molar pregnancies from the definition of
miscarriage showed similar results as the main analysis (S2 Fig).
Adjusted results were largely consistent when stratified by women’s age (dichtomized at age
35) (S3 Fig), with some exceptions. Miscarriage risk was far stronger among older women with
atherosclerosis and PCOS than among younger, while the risk of miscarriage associated with
Cushing syndrome and hyperparathyroidism was stronger among the younger women.
Women with miscarriages who were seen only by general practitioners were slightly youn-
ger (mean 0.8 years) and less likely to have chronic disorders than women seen by specialists
(S2 Table). The risk of miscarriage by maternal age was the same for miscarriages identified in
the patient and general practitioner databases (S4 Fig). The associations between chronic con-
ditions and risk of miscarriage were confined largely to miscarriages referred to specialist
healthcare services (S5 Fig).
The risk of miscarriage was higher if a woman had more than one chronic disease. The
OR of miscarriage with any one chronic disease was 1.01 (95% CI: 0.99 to 1.04; p-value 0.4),
increasing to 1.14 (95% CI: 1.07 to 1.20; p-value <0.001) with any two and 1.49 (95% CI: 1.25
to 1.78; p-value<0.001) with any three (Table 2). The main findings were robust to mutual
adjustment for other underlying chronic disorders (S6 Fig).
Discussion
Combining information from 3 national health registries, we found that the risk of miscar-
riage was largely unaffected by the presence of a chronic disease in the mother. A distinct
increase in miscarriage risk was present among women with cardiometabolic diseases and a
few other illnesses (Crohn’s disease, Cushing syndrome, hypoparathyroidism, and endome-
triosis). Women with two or more chronic diseases were at increased risk regardless of their
illness.
It has previously been shown that women with a history of miscarriages are at increased
risk of subsequent cardiovascular disease [33]. Our data suggest that miscarriage risk does not
cause cardiovascular disease, but rather that preexisting cardiometabolic health might influ-
ence the risk of miscarriage. We observed a clear pattern of increased miscarriage risk across
all 3 diseases included in our category of cardiometabolic diseases (atherosclerosis, hyperten-
sion, and type 2 diabetes). One previous study has reported a link between hypertension and
miscarriage risk [34], although this has not been consistently found [35]. Previous studies also
support an increased risk of miscarriage among women with type 2 diabetes, including 1 case–
control study that retrospectively collected information on history of miscarriages, and 2 clini-
cal chart reviews [9,19,20].
Table 2. The adjusted� odds ratios (OR) of miscarriage according to number of preexisting chronic conditions
registered prior to pregnancy in 593,009 pregnancies.
Number of chronic diseases present before pregnancy Adjusted� OR 95% CI
0 1.00 (reference)
1 1.01 0.99, 1.04
2 1.14 1.07, 1.20
3 or more 1.49 1.25, 1.78
�Adjusted for the woman’s age at the start of pregnancy.
https://doi.org/10.1371/journal.pmed.1003603.t002
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Taking these results together, cardiometabolic health seems an important contributor to a
successful pregnancy. It is already well established that women with cardiovascular risk fac-
tors are at increased risk of preeclampsia and preterm delivery [36]. It would not be surpris-
ing if miscarriage risk should be added to this list. Women undergo extensive hemodynamic
and metabolic changes during pregnancy, with an increase in blood volume, heart rate, glu-
cose levels, and an altered lipid profile [37–39]. It is plausible that women with poorer cardi-
ometabolic health prior to pregnancy (such as elevated blood pressure or glucose levels)
might not adapt as well to pregnancy, rendering them at higher risk of miscarriage. These
underlying biological mechanisms deserve further exploration. An increased risk of miscar-
riage among women with Cushing syndrome could also be related to cardiometabolic mech-
anisms [23].
A meta-analysis of 9 retrospective studies of women with endometriosis suggested an
increased history of miscarriage [40]. A previous prospective study also found an increased
risk with endometriosis [41]. A possible biological pathway might be the progesterone resis-
tance in women with endometriosis, leading to dysregulation of genes important in embryo
implantation and the subsequent greater risk of pregnancy loss [42,43].
A higher risk of miscarriage among women with Crohn’s disease has not previously been
reported, although other autoimmune diseases have been linked to miscarriage risk [7–11,23].
We likewise saw borderline increased risk with other autoimmune conditions. Pregnant
women undergo a shift from a Th1 immune profile (which often characterizes autoimmune
disorders) to a Th2 profile (which often characterizes allergic disorders), and this shift helps
to ensure a successful pregnancy by facilitating an immune tolerance towards the embryo
[44,45]. An insufficient immune adaptation during pregnancy may be associated with an
increased risk of fetal loss [46].
Limitations and strengths
Our study had important limitations. We acknowledge that the strict definition of miscarriage
refers to uterine pregnancies. In our registry study, we defined the outcome as miscarriages or
pregnancies that did not survive to 16 weeks; ectopic pregnancies were excluded. We were also
unable to adjust for some potential confounding factors. Women’s socioeconomic position
and lifestyle characteristics (e.g., body mass index and smoking during pregnancy) have been
reported to be associated with the risk of miscarriage [47–49]. Uncontrolled confounding by
these factors might have contributed to our results, especially for hypertension and type 2 dia-
betes. We used E-values to estimate the magnitude of the relationship that any unmeasured
confounder would have to have to completely explain away our findings [50]. An unmeasured
confounder would have to be associated with a 2-fold increased risk of both miscarriage and
type 2 diabetes to completely attenuate their observed association, while the unmeasured con-
founder would have to be associated with a 1.74 increased risk of both miscarriage and endo-
metriosis to completely attenuate their observed association. We were able to identify only
miscarriages that resulted in contact with healthcare services (primary or secondary healthcare
services). Very early miscarriages where the woman did not know she was pregnant or did not
choose to seek medical attention could not be included. We also acknowledge that defining
pregnancy outcomes based on administrative codes in the registries might have caused mis-
classification due to our inability to confirm the outcome by clinical examinations. Our find-
ings might also not be generalizable to populations with different ethnic compositions or
populations without universal healthcare services. We might have underestimated the number
of women with chronic diseases based on information from the registries. This could have
resulted in an attenuation of the observed associations due to the presence of chronic diseases
PLOS MEDICINE Chronic diseases and miscarriage
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also among some women defined as disease free. However, the registration of chronic diseases
in the registries have been shown to have a high validity [31,51].
We also did not have information on treatment the women may have been receiving for
these conditions, so we cannot distinguish between the effects of underlying diseases and the
medications used to treat those diseases. The proportion of women with preexisting chronic
conditions is also likely underestimated, as compared with the prevalence of some of these dis-
eases from other pregnant populations [52,53]. This may be due in part to our conservative
approach, requiring 2 diagnostic registrations in order to assign a disease to a woman.
In our previous study [32], based on pregnancies in the birth registry and the patient regis-
try, the total risk of miscarriage risk was 13%, which captured miscarriages seen by specialists
healthcare services. In the present analysis, we were able to add miscarriages diagnosed by gen-
eral practitioners, which increased the risk of miscarriage to 16%. While this is at the upper
end of the usual range, it is similar to reports from a British general practitioner database [54].
Our study is, to our knowledge, unique in its size (a whole nation), its inclusion of all recog-
nized pregnancies seen by primary or specialist healthcare services, and its basis in recorded
medical data.
In conclusion, maternal chronic diseases were largely unassociated with increased risk of
miscarriage, although diseases related to cardiometabolic health were consistently linked to
elevated miscarriage risk. A better understanding of the potential biological processes underly-
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